Intravenous Immunoglobulin (IVIg) Industry Research Report 2024
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
According to APO Research, the global Intravenous Immunoglobulin (IVIg) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Immunoglobulin (IVIg), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Immunoglobulin (IVIg).
The report will help the Intravenous Immunoglobulin (IVIg) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Intravenous Immunoglobulin (IVIg) market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Immunoglobulin (IVIg) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Immunoglobulin (IVIg) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravenous Immunoglobulin (IVIg) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Immunoglobulin (IVIg).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Intravenous Immunoglobulin (IVIg) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Intravenous Immunoglobulin (IVIg) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Intravenous Immunoglobulin (IVIg) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Immunoglobulin (IVIg), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Immunoglobulin (IVIg).
The report will help the Intravenous Immunoglobulin (IVIg) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Intravenous Immunoglobulin (IVIg) market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Immunoglobulin (IVIg) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Baxter
- Grifols
- CSL
- Octapharma
- Biotest
- Kedrion
- Hualan Bio
- CNBG
- Shanghai RAAS
- CBPO
- LFB Group
- BPL
- Sichuan Yuanda Shuyang
- IVIg Liquid
- IVIg Powder
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Immunoglobulin (IVIg) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravenous Immunoglobulin (IVIg) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Immunoglobulin (IVIg).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Intravenous Immunoglobulin (IVIg) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Intravenous Immunoglobulin (IVIg) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size (2019-2030) & (US$ Million)
2.2.2 Global Intravenous Immunoglobulin (IVIg) Sales (2019-2030)
2.2.3 Global Intravenous Immunoglobulin (IVIg) Market Average Price (2019-2030)
2.3 Intravenous Immunoglobulin (IVIg) by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 IVIg Liquid
2.3.3 IVIg Powder
2.4 Intravenous Immunoglobulin (IVIg) by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Immunodeficiency
2.4.3 Autoimmune Disease
2.4.4 Acute Infection
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Intravenous Immunoglobulin (IVIg) Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) of Manufacturers (2019-2024)
3.3 Global Intravenous Immunoglobulin (IVIg) Revenue of Manufacturers (2019-2024)
3.4 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2019-2024)
3.5 Global Intravenous Immunoglobulin (IVIg) Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Intravenous Immunoglobulin (IVIg), Product Type & Application
3.8 Global Manufacturers of Intravenous Immunoglobulin (IVIg), Date of Enter into This Industry
3.9 Global Intravenous Immunoglobulin (IVIg) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Baxter
4.1.1 Baxter Company Information
4.1.2 Baxter Business Overview
4.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
4.1.5 Baxter Recent Developments
4.2 Grifols
4.2.1 Grifols Company Information
4.2.2 Grifols Business Overview
4.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
4.2.5 Grifols Recent Developments
4.3 CSL
4.3.1 CSL Company Information
4.3.2 CSL Business Overview
4.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
4.3.5 CSL Recent Developments
4.4 Octapharma
4.4.1 Octapharma Company Information
4.4.2 Octapharma Business Overview
4.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
4.4.5 Octapharma Recent Developments
4.5 Biotest
4.5.1 Biotest Company Information
4.5.2 Biotest Business Overview
4.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
4.5.5 Biotest Recent Developments
4.6 Kedrion
4.6.1 Kedrion Company Information
4.6.2 Kedrion Business Overview
4.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
4.6.5 Kedrion Recent Developments
4.7 Hualan Bio
4.7.1 Hualan Bio Company Information
4.7.2 Hualan Bio Business Overview
4.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
4.7.5 Hualan Bio Recent Developments
4.8 CNBG
4.8.1 CNBG Company Information
4.8.2 CNBG Business Overview
4.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
4.8.5 CNBG Recent Developments
4.9 Shanghai RAAS
4.9.1 Shanghai RAAS Company Information
4.9.2 Shanghai RAAS Business Overview
4.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
4.9.5 Shanghai RAAS Recent Developments
4.10 CBPO
4.10.1 CBPO Company Information
4.10.2 CBPO Business Overview
4.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
4.10.5 CBPO Recent Developments
4.11 LFB Group
4.11.1 LFB Group Company Information
4.11.2 LFB Group Business Overview
4.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
4.11.5 LFB Group Recent Developments
4.12 BPL
4.12.1 BPL Company Information
4.12.2 BPL Business Overview
4.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
4.12.5 BPL Recent Developments
4.13 Sichuan Yuanda Shuyang
4.13.1 Sichuan Yuanda Shuyang Company Information
4.13.2 Sichuan Yuanda Shuyang Business Overview
4.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
4.13.5 Sichuan Yuanda Shuyang Recent Developments
5 GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET SCENARIO BY REGION
5.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2019-2030
5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2019-2024
5.2.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2025-2030
5.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2019-2030
5.3.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2019-2024
5.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2025-2030
5.4 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
5.4.1 North America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
5.4.3 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
5.5.1 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
5.5.3 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
5.6.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
5.6.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
5.7.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
5.7.3 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
5.8.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
5.8.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030)
6.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030) & (K Bottle)
6.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2019-2030)
6.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2030)
6.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2019-2030)
6.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030)
7.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030) & (K Bottle)
7.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2019-2030)
7.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2030)
7.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2019-2030)
7.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Intravenous Immunoglobulin (IVIg) Value Chain Analysis
8.1.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Intravenous Immunoglobulin (IVIg) Production Mode & Process
8.2 Intravenous Immunoglobulin (IVIg) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Intravenous Immunoglobulin (IVIg) Distributors
8.2.3 Intravenous Immunoglobulin (IVIg) Customers
9 GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) ANALYZING MARKET DYNAMICS
9.1 Intravenous Immunoglobulin (IVIg) Industry Trends
9.2 Intravenous Immunoglobulin (IVIg) Industry Drivers
9.3 Intravenous Immunoglobulin (IVIg) Industry Opportunities and Challenges
9.4 Intravenous Immunoglobulin (IVIg) Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size (2019-2030) & (US$ Million)
2.2.2 Global Intravenous Immunoglobulin (IVIg) Sales (2019-2030)
2.2.3 Global Intravenous Immunoglobulin (IVIg) Market Average Price (2019-2030)
2.3 Intravenous Immunoglobulin (IVIg) by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 IVIg Liquid
2.3.3 IVIg Powder
2.4 Intravenous Immunoglobulin (IVIg) by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Immunodeficiency
2.4.3 Autoimmune Disease
2.4.4 Acute Infection
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Intravenous Immunoglobulin (IVIg) Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) of Manufacturers (2019-2024)
3.3 Global Intravenous Immunoglobulin (IVIg) Revenue of Manufacturers (2019-2024)
3.4 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2019-2024)
3.5 Global Intravenous Immunoglobulin (IVIg) Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Intravenous Immunoglobulin (IVIg), Product Type & Application
3.8 Global Manufacturers of Intravenous Immunoglobulin (IVIg), Date of Enter into This Industry
3.9 Global Intravenous Immunoglobulin (IVIg) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Baxter
4.1.1 Baxter Company Information
4.1.2 Baxter Business Overview
4.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
4.1.5 Baxter Recent Developments
4.2 Grifols
4.2.1 Grifols Company Information
4.2.2 Grifols Business Overview
4.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
4.2.5 Grifols Recent Developments
4.3 CSL
4.3.1 CSL Company Information
4.3.2 CSL Business Overview
4.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
4.3.5 CSL Recent Developments
4.4 Octapharma
4.4.1 Octapharma Company Information
4.4.2 Octapharma Business Overview
4.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
4.4.5 Octapharma Recent Developments
4.5 Biotest
4.5.1 Biotest Company Information
4.5.2 Biotest Business Overview
4.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
4.5.5 Biotest Recent Developments
4.6 Kedrion
4.6.1 Kedrion Company Information
4.6.2 Kedrion Business Overview
4.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
4.6.5 Kedrion Recent Developments
4.7 Hualan Bio
4.7.1 Hualan Bio Company Information
4.7.2 Hualan Bio Business Overview
4.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
4.7.5 Hualan Bio Recent Developments
4.8 CNBG
4.8.1 CNBG Company Information
4.8.2 CNBG Business Overview
4.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
4.8.5 CNBG Recent Developments
4.9 Shanghai RAAS
4.9.1 Shanghai RAAS Company Information
4.9.2 Shanghai RAAS Business Overview
4.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
4.9.5 Shanghai RAAS Recent Developments
4.10 CBPO
4.10.1 CBPO Company Information
4.10.2 CBPO Business Overview
4.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
4.10.5 CBPO Recent Developments
4.11 LFB Group
4.11.1 LFB Group Company Information
4.11.2 LFB Group Business Overview
4.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
4.11.5 LFB Group Recent Developments
4.12 BPL
4.12.1 BPL Company Information
4.12.2 BPL Business Overview
4.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
4.12.5 BPL Recent Developments
4.13 Sichuan Yuanda Shuyang
4.13.1 Sichuan Yuanda Shuyang Company Information
4.13.2 Sichuan Yuanda Shuyang Business Overview
4.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
4.13.5 Sichuan Yuanda Shuyang Recent Developments
5 GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET SCENARIO BY REGION
5.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2019-2030
5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2019-2024
5.2.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2025-2030
5.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2019-2030
5.3.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2019-2024
5.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2025-2030
5.4 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
5.4.1 North America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
5.4.3 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
5.5.1 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
5.5.3 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
5.6.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
5.6.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
5.7.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
5.7.3 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
5.8.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
5.8.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030)
6.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030) & (K Bottle)
6.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2019-2030)
6.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2030)
6.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2019-2030)
6.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030)
7.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030) & (K Bottle)
7.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2019-2030)
7.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2030)
7.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2019-2030)
7.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Intravenous Immunoglobulin (IVIg) Value Chain Analysis
8.1.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Intravenous Immunoglobulin (IVIg) Production Mode & Process
8.2 Intravenous Immunoglobulin (IVIg) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Intravenous Immunoglobulin (IVIg) Distributors
8.2.3 Intravenous Immunoglobulin (IVIg) Customers
9 GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) ANALYZING MARKET DYNAMICS
9.1 Intravenous Immunoglobulin (IVIg) Industry Trends
9.2 Intravenous Immunoglobulin (IVIg) Industry Drivers
9.3 Intravenous Immunoglobulin (IVIg) Industry Opportunities and Challenges
9.4 Intravenous Immunoglobulin (IVIg) Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
